咪唑立宾

Mizoribine

未知生产厂商

Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

适应症

预防器官移植时排斥反应。

技术标识符

化学式: C₉H₁₃N₃O₆
CAS 编号: 50924-49-7
UNII ID: 4JR41A10VP

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Mizoribine tablet with improved colour
CN 1178652 C申请人: ASAHI CHEMICAL IND优先权: 2000
CN
Uses for inhibitors of inosine monophosphate dehydrogenase
US 2004127435 A1申请人: UNIV CALIFORNIA优先权: 2003
US
Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
US 2005255071 A1申请人: AVENTIS PHARMA GMBH优先权: 2005
US
Therapeutic agent for ulcerative colitis comprising mizoribine
CN 101687899 B申请人: ASAHI KASEI KURARAY MEDICAL CO优先权: 2008
CN
一种咪唑立宾在制备预防口蹄疫病毒感染的药物中的应用
CN 109864993 B申请人: 中国农业科学院兰州兽医研究所优先权: 2019
CN
Feline calicivirus inhibitor with nitazoxanide and mizoribine as effective components
CN 111437285 A申请人: UNIV JILIN AGRICULTURAL优先权: 2020
CN
咪唑立宾以及包含咪唑立宾的组合物的用途
CN 112220749 B申请人: 厦门上佳源生物科技有限公司优先权: 2020
CN
Mizoribine oral instant film agent and preparation method thereof
CN 116211833 A申请人: NANJING HICIN PHARMACEUTICAL CO LTD优先权: 2021
CN
Application of mizoribine in preparation of preparation for inhibiting influenza virus
CN 120189426 A申请人: HARBIN VETERINARY RES INSTITUTE CAAS HARBIN BRANCH OF CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER优先权: 2025
CN
Application of synthetic route for inhibiting purine nucleotide in prevention or treatment of orthopoxvirus infection
CN 120695188 A申请人: RENJI HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE优先权: 2025
CN

药物